SEHK:2389

Stock Analysis Report

Beijing Enterprises Medical and Health Industry Group

Executive Summary

Beijing Enterprises Medical and Health Industry Group Limited, an investment holding company, provides medical care, health care, and geriatric care related services and products in the People’s Republic of China.

Snowflake

Fundamentals

Adequate balance sheet and overvalued.

Share Price & News

How has Beijing Enterprises Medical and Health Industry Group's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-2.0%

2389

2.4%

HK Medical Equipment

3.1%

HK Market


1 Year Return

-21.9%

2389

9.8%

HK Medical Equipment

0.5%

HK Market

Return vs Industry: 2389 underperformed the Hong Kong Medical Equipment industry which returned 9.8% over the past year.

Return vs Market: 2389 underperformed the Hong Kong Market which returned 0.5% over the past year.


Shareholder returns

2389IndustryMarket
7 Day-2.0%2.4%3.1%
30 Day1.2%-0.4%-1.8%
90 Day3.3%20.2%-4.8%
1 Year-21.9%-21.9%10.9%9.8%4.1%0.5%
3 Year-44.4%-44.4%12.4%8.9%15.8%4.2%
5 Year-60.9%-60.9%0.5%-4.5%18.9%-0.9%

Price Volatility Vs. Market

How volatile is Beijing Enterprises Medical and Health Industry Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Beijing Enterprises Medical and Health Industry Group undervalued compared to its fair value and its price relative to the market?

0.55x

Price to Book (PB) ratio


Share Price vs. Fair Value

Undervalued: Insufficient data to calculate 2389's fair value to establish if it is undervalued.

Significantly Undervalued: Insufficient data to calculate 2389's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: 2389 is unprofitable, so we can't compare its PE Ratio to the Medical Equipment industry average.

PE vs Market: 2389 is unprofitable, so we can't compare its PE Ratio to the Hong Kong market.


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate 2389's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 2389 is good value based on its PB Ratio (0.5x) compared to the HK Medical Equipment industry average (1.7x).


Next Steps

Future Growth

How is Beijing Enterprises Medical and Health Industry Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

43.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 2389 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 2389 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 2389 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: Insufficient data to determine if 2389's revenue is forecast to grow faster than the Hong Kong market.

High Growth Revenue: Insufficient data to determine if 2389's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: Insufficient data to determine if 2389's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Beijing Enterprises Medical and Health Industry Group performed over the past 5 years?

41.7%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: 2389 is unprofitable, but has reduced losses over the past 5 years at a rate of 41.7% per year.

Accelerating Growth: Unable to compare 2389's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 2389 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (50.2%).


Return on Equity

High ROE: 2389 has a negative Return on Equity (-0.84%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: 2389 is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: 2389 is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Beijing Enterprises Medical and Health Industry Group's financial position?


Financial Position Analysis

Short Term Liabilities: 2389's short term assets (HK$1.1B) exceeds its short term liabilities (HK$346.1M)

Long Term Liabilities: 2389's short term assets (1.1B) exceeds its long term liabilities (162.0M)


Debt to Equity History and Analysis

Debt Level: 2389's debt to equity ratio (4.4%) is considered satisfactory

Reducing Debt: 2389's debt to equity ratio has reduced from 49% to 4.4% over the past 5 years.

Debt Coverage: 2389's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if 2389's interest payments on its debt are well covered by EBIT.


Balance Sheet

Inventory Level: 2389 has a low level of unsold assets or inventory.

Debt Coverage by Assets: 2389's debt is covered by short term assets (assets are 8.028210x debt).


Next Steps

Dividend

What is Beijing Enterprises Medical and Health Industry Group's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%2.3%markettop25%6.3%industryaverage1.2%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate 2389's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate 2389's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if 2389's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 2389's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 2389's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.


Next Steps

Management

What is the CEO of Beijing Enterprises Medical and Health Industry Group's salary, the management and board of directors tenure and is there insider trading?

4.6yrs

Average management tenure


CEO

Jing Ming Zhang (54yo)

5.1yrs

Tenure

HK$714,000

Compensation

Mr. Jing Ming Zhang has been the Joint Chief Executive Officer of Genvon Group Limited since April 21, 2015 and has been its Executive Director since September 23, 2014. Mr. Zhang served as the Chief Execu ...


Management Age and Tenure

4.6yrs

Average Tenure

50yo

Average Age

Experienced Management: 2389's management team is considered experienced (4.6 years average tenure).


Board Age and Tenure

5.1yrs

Average Tenure

52.5yo

Average Age

Experienced Board: 2389's board of directors are considered experienced (5.1 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyHK$1,003,53113 Dec 18
Beijing Investment Co
EntityCompany
Shares4,350,000
Max PriceHK$0.23

Ownership Breakdown


Management Team

  • Shiang Chi Hu (58yo)

    Executive Director

    • Tenure: 4.4yrs
    • Compensation: HK$649.00k
  • Zheng Chun Wang (54yo)

    Executive Director

    • Tenure: 11.3yrs
    • Compensation: HK$842.00k
  • Michael Siu (51yo)

    Executive Director

    • Tenure: 2.4yrs
    • Compensation: HK$180.00k
  • Ka Tak Lam (37yo)

    CFO, Financial Controller & Company Secretary

    • Tenure: 4.6yrs
  • Xue Heng Liu (46yo)

    Joint CEO & Executive Director

    • Tenure: 5.1yrs
    • Compensation: HK$4.97m
  • Shi Xing Zhu (49yo)

    Chairman of the Board

    • Tenure: 4.7yrs
    • Compensation: HK$5.56m
  • Jing Ming Zhang (54yo)

    Joint Chief Executive Officer & Executive Director

    • Tenure: 5.1yrs
    • Compensation: HK$714.00k
  • Shan Chao Gu (49yo)

    Executive Director

    • Tenure: 5.1yrs
    • Compensation: HK$5.09m

Board Members

  • Shiang Chi Hu (58yo)

    Executive Director

    • Tenure: 4.4yrs
    • Compensation: HK$649.00k
  • Keith Tse (45yo)

    Independent Non-Executive Director

    • Tenure: 5.1yrs
    • Compensation: HK$287.00k
  • Zheng Chun Wang (54yo)

    Executive Director

    • Tenure: 11.3yrs
    • Compensation: HK$842.00k
  • Michael Siu (51yo)

    Executive Director

    • Tenure: 2.4yrs
    • Compensation: HK$180.00k
  • Xue Heng Liu (46yo)

    Joint CEO & Executive Director

    • Tenure: 5.1yrs
    • Compensation: HK$4.97m
  • Shi Xing Zhu (49yo)

    Chairman of the Board

    • Tenure: 4.7yrs
    • Compensation: HK$5.56m
  • Jing Ming Zhang (54yo)

    Joint Chief Executive Officer & Executive Director

    • Tenure: 5.1yrs
    • Compensation: HK$714.00k
  • Shan Chao Gu (49yo)

    Executive Director

    • Tenure: 5.1yrs
    • Compensation: HK$5.09m
  • Yong Xin Wu (55yo)

    Independent Non-Executive Director

    • Tenure: 5.1yrs
    • Compensation: HK$287.00k
  • Gary Zhou (58yo)

    Independent Non-Executive Director

    • Tenure: 3.7yrs
    • Compensation: HK$180.00k

Company Information

Beijing Enterprises Medical and Health Industry Group Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Beijing Enterprises Medical and Health Industry Group Limited
  • Ticker: 2389
  • Exchange: SEHK
  • Founded: 1995
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: HK$1.520b
  • Shares outstanding: 6.08b
  • Website: https://www.bemh.com.hk

Number of Employees


Location

  • Beijing Enterprises Medical and Health Industry Group Limited
  • Greenfield Tower
  • 21st Floor, Room 2108
  • Tsim Sha Tsui East
  • Kowloon
  • Hong Kong

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
2389SEHK (The Stock Exchange of Hong Kong Ltd.)YesOrdinary SharesHKHKDApr 2002

Biography

Beijing Enterprises Medical and Health Industry Group Limited, an investment holding company, provides medical care, health care, and geriatric care related services and products in the People’s Republic o ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/17 12:33
End of Day Share Price2019/10/17 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.